Researchers track Real-World side effects of ofev in lung disease patients
NCT ID NCT04325217
First seen Jun 27, 2026 · Last updated Jul 23, 2026 · Updated 2 times
Summary
This study monitors the long-term safety of the drug Ofev in people with lung disease caused by scleroderma. Researchers are tracking side effects like diarrhea and nausea in 586 patients in Japan who are starting Ofev for the first time. The goal is to see how common these side effects are in everyday use, not to test if the drug works.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG DISEASES, INTERSTITIAL are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nippon Boehringer Ingelheim Co., Ltd.
Tokyo, 1416017, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can scans replace breathing tests to monitor lung scarring?
- Skin patch could replace needle sticks during exercise tests
- Pigeon Lovers' lung disease: genes may hold the key
- New study tracks lung disease in rheumatic patients
- Lung biopsy without a breathing tube? small study tests a gentler approach
- New injection aims to ease lung pressure in scarred lungs